Advanced search
Publication Cover
OncoImmunology Volume 9, 2020 - Issue 1
Submit an article Journal homepage
3,418
Views
25
CrossRef citations to date
0
Altmetric
Review

The consensus immunoscore: toward a new classification of colorectal cancer

Anastasia Lanzia Laboratory of Integrative Cancer Immunology, INSERM, Paris, France;b Equipe Labellisée Ligue Contre le Cancer, Paris, France;c Centre de Recherche des Cordeliers, Sorbonne Université, Sorbonne Paris Cité, Université de Paris, Paris, FranceView further author information
,
Franck Pagèsa Laboratory of Integrative Cancer Immunology, INSERM, Paris, France;b Equipe Labellisée Ligue Contre le Cancer, Paris, France;c Centre de Recherche des Cordeliers, Sorbonne Université, Sorbonne Paris Cité, Université de Paris, Paris, France;d Immunomonitoring Platform, Laboratory of Immunology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, FranceView further author information
,
Christine Lagorce-Pagèse Department of Pathology, AP-HP, Assistance Publique-Hopitaux de Paris, Georges Pompidou European Hospital, Paris, FranceView further author information
&
Jérôme Galona Laboratory of Integrative Cancer Immunology, INSERM, Paris, France;b Equipe Labellisée Ligue Contre le Cancer, Paris, France;c Centre de Recherche des Cordeliers, Sorbonne Université, Sorbonne Paris Cité, Université de Paris, Paris, FranceCorrespondence[email protected]
View further author information
Article: 1789032 | Received 24 Jun 2020, Accepted 25 Jun 2020, Published online: 11 Jul 2020

References

  • Quezada-Marin J, Lam AK, Ochiai A, Odze R, Washington MK, Fukuyama M, Rugge M, Kimstra DS, Nagtegaal ID, Tan PH, et al. Gastrointestinal tissue-based molecular biomarkers: A practical categorization based on the 2019 WHO classification of epithelial digestive tumours. Histopathology. 2020. PMID: 32320495. doi:10.1111/his.14120.
  • Zhang X, Yang J, Du L, Zhou Y, Li K. The prognostic value of immunoscore in patients with cancer: A pooled analysis of 10,328 patients. Int J Biol Markers. 2020:1724600820927409. PMID: 32538254. doi:10.1177/1724600820927409.
  • Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960–3. PMID: 17008531. doi:10.1126/science.1129139.
  • Galon J, Fox BA, Bifulco CB, Masucci G, Rau T, Botti G, Marincola FM, Ciliberto G, Pages F, Ascierto PA, et al. Immunoscore and immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015. J Transl Med. 2016;14:273. PMID: 27650038. doi:10.1186/s12967-016-1029-z.
  • Kirilovsky A, Marliot F, El Sissy C, Haicheur N, Galon J, Pagès F. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients. Int Immunol. 2016;28:373–382. PMID: 27121213. doi:10.1093/intimm/dxw021.
  • Pages F, Galon J, Fridman WH. The essential role of the in situ immune reaction in human colorectal cancer. J Leukoc Biol. 2008;84:981–987. PMID: 18559950. doi:10.1189/jlb.1107773.
  • Pages F, Mlecnik B, Marliot F, Bindea G, Ou F-S, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, et al. International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet. 2018;391:2128–2139. PMID: 29754777. doi:10.1016/S0140-6736(18)30789-X.
  • Sinicrope FA, Shi Q, Hermitte F, Zemla TJ, Mlecnik B, Benson AB, Gill S, Goldberg RM, Kahlenberg MS, Nair SG, et al. Contribution of immunoscore and molecular features to survival prediction in stage III colon cancer. JNCI Cancer Spectr. 2020;4:pkaa023. PMID: 32455336. doi:10.1093/jncics/pkaa023.
  • Pagès F, André T, Taieb J, Vernerey D, Henriques J, Borg C, Marliot F, Ben Jannet R, Louvet C, Mineur L, et al. Prognostic and predictive value of the immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study. Ann Oncol. 2020;31:921–929. PMID: 32294529. doi:10.1016/j.annonc.2020.03.310.
  • Angelova M, Mlecnik B, Vasaturo A, Bindea G, Fredriksen T, Lafontaine L, Buttard B, Morgand E, Bruni D, Jouret-Mourin A, et al. Evolution of metastases in space and time under immune selection. Cell. 2018;175:751–765 e716. PMID: 30318143. doi:10.1016/j.cell.2018.09.018.
  • Mlecnik B, Van den Eynde M, Bindea G, Church SE, Vasaturo A, Fredriksen T, Lafontaine L, Haicheur N, Marliot F, Debetancourt D, et al. Comprehensive Intrametastatic Immune Quantification And Major Impact Of Immunoscore On Survival. J Natl Cancer Inst. 2018;110:97–108. PMID: 28922789. doi:10.1093/jnci/djx123.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.